» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 701-725 of 1083 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
derived from Teucrium chamaedrys extract on visual function indices in patients with COVID-19 Design: A (...) participants of this study are patients with COVID-19 referred to Tehran Army hospitals. Patients are divided (...) group: patients with COVID-19 that receiving 0.04% eye drops containing the effective combination of
IRCTID: IRCT20211223053497N1
Study aim: Achieve an appropriate treatment protocol for COVID-19 Design: Randomized parallel (...) : Inclusion criteria: Diagnosis of COVID-19 based on either ground glass appearance in chest CT scan or positive RTPCR test for COVID-19; Requiring hospitalization; Patient's age between 16 and 100 years; Signed
IRCTID: IRCT20200318046812N2
  1. Evaluation of safety and efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra on the need for intensive care unit treatment in patients with COVID-19; a randomized, multicenter, parallel groups, open label study
  2. Evaluation of safety and efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in hospitalized patients with COVID-19
  3. The effect of naproxen on the healing process of patients with COVID-19
  4. Evaluation of the efficiency of hydroxychloroquine drug regimen in comparison with hydroxychloroquine + azithromycin in hospitalized patients with covid-19 in the intensive care unit
  5. Evaluation of treatment strategy Included : hydroxychloroquine ,naproxen and oseltamivir for outpatient patients with Covid 19
  6. The effect of adding SOVODAK (sofosbuvir+daclatasvir) to the treatment protocol of COVID-19 outpatients: A Clinical Trial Study
  7. Evaluation of the effect of herbal medicine containing Saatar, Hofarigon and Fennel on reduction of pulmonary complications of COVID-19 in patients: a clinical trial
  8. Evaluation of safety and effectiveness of favipiravir in comparison with Tenofovir Alafenamid in hospitalized patients with COVID-19
  9. Comparison of the efficacy and safety of Atazanavir/Ritonavir plus Hydroxychloroquine regimen with Lopinavir/Ritonavir plus Hydroxychloroquine regimen in patients with moderate COVID-19, A randomized, double-blind study
  10. Safety and Effectiveness of azithromycin in Patients with COVID-19 Referred to zeiaeian Hospital : A clinical trial study
Study aim: Evaluating the effectiveness of CURCUDEN products as adjunctive therapy in the treatment of pneumonia in patients with COVID-19 Design: A phase 3 randomized clinical trial with control and (...) treatment regimen for COVID-19 according to the national protocol.From the day of entrance,the Sepsis
IRCTID: IRCT20170128032241N3
patients with Covid-19. The random number table will use for randomization, and participants will be (...) Study aim: Study the effect of Benson's relaxation technique on self_care and anxiety of post-Covid 19patients in Shafa hospital of Kelishad city of Isfahan in 2021 Design: This randomized clinical trial is a
IRCTID: IRCT20210518051340N1
patients with covid-19 who undergo coronary angioplasty (percutaneous coronary interventions) with the (...) myocardial infarction (with or without ST-segment elevation), concomitant Covid-19 infection Exclusion (...) hospital. Patients presenting with acute MI who are also suffering from covid will be randomly divided into
IRCTID: IRCT20220813055675N1
  1. Comparison the short-term outcomes of Ticagrelor versus Clopidogrel treatment in patients with myocardial infarction undergoing Percutaneous Coronary Intervention
  2. Comparison of ticagrelor with clopidogrel on myocardial blood flow and prognosis of patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
  3. Comparing the efficacy of Ticagrelor and Clopidogrel in patients with acute ischemic stroke or transient ischemic attack(TIA)
  4. Assessment of Clopidogrel plus Eptifibatide versus Ticagrelor Treatment for No-reflow in patients with acute ST-Elevation MI referring for Primary Percutaneous coronary Intervention
  5. Ticagrelor plus Aspirin vs Clopidogrel plus Aspirin in MInor Non-cardioembolic Ischemic Stroke (TACAMINIS)
  6. Evaluation the effect of colchicine on the outcome and noreflow of blood in the coronary arteries in patients undergoing primary percutaneous coronary intervention in patients with acute myocardial infarction
  7. Comparing the effect of Loading Doses of Clopidogrel and Prasugrel on the incidence of myocardial injury in the Candidates for Elective Percutaneous Coronary Intervention
  8. Effect of omega 3 on inflammatory marker, hs-CRP, and 30-days major adverse cardiac effects (MACE) after percutaneous coronary intervention (PCI) in chronic kidney disease patients (CKD)
  9. Effect of omega 3 on cardiac necrosis biomarkers, TnI and CK-MB, and 30-days major adverse cardiac effects (MACE) after percutaneous coronary intervention (PCI) in chronic kidney disease patients (CKD)
  10. Comparative bioequivalence study of Ticagrelor 90 mg F.C. Tablet of Zist Arvand Pharmed. and Brilinta®of Asterazeneca Sciences as reference in 24 healthy male under fasting condition
Study aim: The effectiveness of Corcomex in reducing the symptoms of Covid-19 Design: This clinical trial has a control group, double-blind, randomized, in phase 2 and on 100 people. The method of randomization was simple randomization. Settings and conduct: The study was conducted in the city of Sari. The
IRCTID: IRCT20230125057216N1
Study aim: Determining the clinical course of the disease in patients with Covid-19 infection with or without antibiotics Design: A clinical trial with a control group, with parallel groups, three (...) conduct: The study is performed on patients admitted to Hajar Hospital in Shahrekord with Covid disease
IRCTID: IRCT20210510051248N1
Covid 19 or encountering Covid-19 patients,having diploma or higher,age between 20-50,Having the consent (...) Study aim: Determining the extent of mental distress,avoidance,unwanted thoughts,hyperactivity,depression and anxiety in health workers while serving in the Covid-19crisis Design: The research is a
IRCTID: IRCT20180502039508N2
any experimental treatment for COVID-19 before hand, Heart rate < 60/min, currently on amiodarone (...) air or the Pa02/Fi02 ratio ≤300mgHg , Laboratory (RT-PCR) confirming the infection with 2019-Covid (...) patients admitted in COVID ward from 3/4/2021 with definitive diagnosis of moderate COVID19. For one arm
IRCTID: IRCT20180302038915N1
Study aim: To evaluate the incidence of COVID-19, 2 weeks after the 2nd dose Design: A phase III (...) pregnant/breastfeeding. Exclusion: Subjects with active infection with signs of COVID-19 Subjects with T≥38 (...) vaccinated against COVID-19. They received other authorized vaccines within 28 days prior to the screening
IRCTID: IRCT20150303021315N24
  1. A phase II, Randomized, Two-armed, Double-blind, Placebo controlled trial to evaluate efficacy and safety of an adjuvanted recombinant SARS-CoV-2 spike (S) protein subunit vaccine (SpikoGen®) produced by CinnaGen Co. (Two doses of 25µg with dosing interval of 21 days)
  2. A randomized, two-armed, Placebo controlled (5:1), Double-blind, parallel clinical trial to compare the immunogenicity and safety of SpikoGen® vaccine (an adjuvanted recombinant spike (S) protein produced by CinnaGen Co.) as a booster dose
  3. A non-randomized, three-armed, non-inferiority, open label, parallel clinical trial to compare the immunogenicity and safety of SpikoGen® vaccine (an adjuvanted recombinant spike (S) protein produced by CinnaGen Co.) in children aged 5-12, adolescents aged 12-18 and adults aged 18-40
  4. A single armed, open label, clinical trial to evaluate the immunogenicity of SpikoGen® vaccine as booster dose (Spike protein, produced by CinnaGen company) in kidney transplant patients being fully vaccinated with Sinopharm vaccine
  5. Efficacy, safety, and immunogenicity of Soberana recombinant vaccine (product of Finlay Institute) based on RBD protein subunit of Sars-Cov-2 in a 2-dose regimen with and without a booster dose: a double-blind, randomized, placebo-controlled phase III clinical trial in the Iranian population of 18-80 years
  6. Phase 1, safety, immunogenicity and dose finding for two strengths of 0.5 × 10^6 and 2.5 × 10^6 (TCID50) inactivated SARS-CoV-2 vaccine FAKHRAVAC (MIVAC) injected in two schedules of two doses, 2 and 3 weeks apart in healthy adults aged 18-55 years: a randomized, double blind, placebo controlled, clinical trial
  7. Evaluation of the serological response to the heterologous versus homologous booster vaccinationin in patients receiving autologous hematopoietic stem cell transplantation
  8. Safety and Immunogenicity of Razi Cov-2 recombinant Spike protein vaccine (RAZI Cov Pars) in healthy children and adolescents aged 5-17 years; single group, open label study
  9. Evaluation of SARS-CoV-۲ Vaccine (Pastocovac) effectiveness and serologic response in Patients Receiving Hematopoietic Autologous Stem Cell Transplantation compared to control group: A clinical trial
  10. Phase I, Safety and Immunogenicity of Razi SARS-CoV-2 recombinant Spike protein vaccine (Razi Cov Pars), in healthy adults aged 18-55 years; parallel 4 arms design (adjuvant only and three vaccine doses of 5, 10, and 20 µg/200µl); a Randomised, double blind, clinical trial
with olfactory dysfunction after Covid-19 infection Design: A clinical trial with intervention and (...) : Decreased olfactory or olfactory change after Covid-19 infection At least 3 months have passed since the (...) trauma or olfactory loss before Covid-19 infection - History of illness, surgery, or brain tumor
IRCTID: IRCT20211109053018N1
criteria: Major entry conditions: 1. Inpatients diagnosed with Covid 19. 2. Patients with Covid 19 who wish
IRCTID: IRCT20150819023685N3
patients with Covid-19 Design: This study was designed as a double-blind randomized controlled clinical (...) and exclusion criteria: Inclusion criteria :Includes people with laboratory confirmation of Covid virus 19 Age over 15 years Exclusion criteria Patient request to leave the study for any reason Request
IRCTID: IRCT20201111049348N2
  1. Comparison of the Effect of Alcoholic Extract of Licorice Root and Placebo Capsule on Alpha Tumor Necrosis Factor (TNF-α) Inflammatory Factor Interleukin-6 (IL-6) and Inflammatory Factor 1-Beta (IL-1β) in Patients with Covid-19
  2. Evaluation of the effect of royal jelly consumption on inflammatory mediators including interleukin-1-beta, interleukin-6, interferon-gamma and tumor necrosis factor in patients with multiple sclerosis
  3. Effects of plasmapheresis on respiratory condition and acidosis of patients with unstable complex pelvic fracture and long bones
  4. The effect of saffron on pulmonary function and serum levels of Interleukin-6 and Tumor Necrosis Factor-α in patients with Chronic Obstructive Pulmonary Disease
  5. A clinical trial with the aim of investigating the multi-therapeutic effect of Lactobacillus roteri, Lactobacillus rhamnosus and Bifidobacterium infante on IL-6 and TNF-a cytokines in patients with systemic lupus erythematosus
  6. Comparison of serum inflammatory mediators levels in patients affected by COVID-19 with and without photobiomodulation (PBM)
  7. The effect of vitamin D supplementation on inflammatory cytokines (Interleukin 6, Tumor Necrosis Factor alpha), Brain-derived neurotrophic factor (BDNF), Dopamine, Serotonin, Paroxonase-1 enzyme (PON-1),Total Antioxidant Capacity (TAC), 8-Isoprostane, Soluble intercellular adhesion molecule-1(sICAM-1) and Soluble vascular cell adhesion molecule-1(sVCAM-1) in school- aged children with Attention Deficit Hyperactivity Disorder
  8. Effect of soybean flour enriched bread consumption or usual dietary recommendation on serum levels of inflammatory bio markers, lipid profile, glycemic indices and Anthropometric indices in patients with type 2 diabetes: a randomized controlled trial
  9. Comparison of the effects of Camelina and Sunflower oils on metabolic, inflammatory and anti-inflammatory factors in patients with Non-alcoholic fatty liver
  10. The clinical trial of effects of nanocurcumin supplementation on blood nesfatin, insulin resistance indexes, lipids and inflammatory factors in overweight and obese patients with non-alcoholic fatty liver disease ‎‎(NAFLD)‎
comparing the two masks in coronary patients. Evidence suggests that patients Covid-19 sufferers suffer from (...) ventilation according to the protocol of the Office of Respiratory Failure in Covid-19 of the Ministry of (...) masks on patients with Quid-19, this study was performed. Design: After approving the proposal and
IRCTID: IRCT20210424051061N1
  1. Evaluation of low dose whole lung irradiation for treatment of resistant COVID-19 pneumonia
  2. Comparison of Comfortability and Effectiveness of Total Face Mask and Oronasal Mask in Non-invasive Positive Pressure Ventilation in Patients with Acute Respiratory Failure
  3. Efficacy of nasal high frequency oscillatory ventilation versus nasal continuous positive airway pressure and double positive airway pressure in neonates less than 34 weeks with respiratory distress syndrome: a randomized controlled trial.
  4. Effects of selected music-therapy on anxiety severity quantity and some indicators physiological of patients acute respiratory failure covid-19 undergoing non-invasive mechanical ventilation
  5. Therapeutic effect of Nasal high frequency ventilation(NHFV) versus nasal continuous positive airway pressure(NCPAP) for respiratory distress syndrome in newborn with birth with more than 1000 gram and more than 30 week of gestational age
  6. The comparative effectiveness of airway management in pre-hospital
  7. Comparative Trial of Intermittent CPAP use in Hypoxemic Patients with COVID-19 infection
  8. The effect of CPAP masks on hemodynamic parameters, arterial blood gas and pulmonary complications in patients after open heart surgery
  9. Rapid Shallow Breathing Index Survey: A Predictor of Non-Invasive Ventilation Necessity in Patients with Chronic Obstructive Pulmonary Disease Exacerbation: A prospective descriptive study
  10. Endotracheal intubation with laryngeal mask airway and bougie versus video laryngoscope in patients with difficult airway
Study aim: Evaluation of the effectiveness of sweet almond, oral product in improving Respiratory symptoms of patients with Quaid 19 Design: This study is a Controlled Clinical Trial that is performed on 60 patients with COVID19, with respiratory symptoms. Patients were divided into two random groups
IRCTID: IRCT20180712040446N2
pneumonia caused by covid 19. Participants/Inclusion and exclusion criteria: Inclusion criteria up18 year-olds with moderate-intensity pneumonia caused by Covid 19 whose disease has been proven on the basis of (...) usual treatment for covid 19 infection. Main outcome variables: Time to clinical recovery 14 days
IRCTID: IRCT20200509047373N1
exclusion criteria: Include criteria: 1. possibility of involving to Covid-19 2. PaO2/FiO2 < 300 mm Hg or (...) Settings and conduct: A clinical trial will be performed on 200 patients suspected of having 19 patients
IRCTID: IRCT20200527047581N1
Study aim: Determination The Eeffect of a Persian Natural Medicine Product based on Tahini Oil on Clinical Signs in Suspected Patients with COVID-19 Design: Clinical trial with control group, with parallel groups, three-way blind, randomized, phase 1 on 100 patients. SNOSE is used for randomization
IRCTID: IRCT20140407017169N2
Study aim: Efficacy and safety of Co-trimoxazole in patients with COVID-19 Design: Clinical trial of the effectiveness of Co-trimoxazole on COVID-19 patients with control and intervention groups (...) , definitive diagnosis of COVID-19 by PCR test, early signs of moderate-severity disease admitted to hospital
IRCTID: IRCT20220407054446N1
olfactory hypersensitivity during COVID-19 Design: Clinical trial with a control group, single-blind (...) patients with COVID-19 referred to Rasoul Akram Hospital who have not had any improvement in their sense of (...) /Inclusion and exclusion criteria: Patients with covid-19 who have an olfactory disorder (anosmia) and the
IRCTID: IRCT20210311050671N1
jujuba, Glycyrrhiza glabra, and Cydonia oblonga) on the symptoms of patients with COVID-19 Design: A (...) with covid-19 are selected from Masih Deneshvari in Tehran, Razi in ghaemshahr, shahid beheshti in (...) 18 and 75 years and a definite diagnosis of the disease of Covid-19 based on the PCR test or lung CT
IRCTID: IRCT20211218053445N1
Study aim: Efficacy of additional treatments (Infliximab, Imatinib) in hospitalized covid-19 patients Design: In parallel randomized clinical trial, information of hospitalized patients with covid-19 (...) -confirmed COVID-19; Adults (age ≥18 years); Not expected to be transferred within 72 hours; In the
IRCTID: IRCT20211221053470N1
psychological distress in patients with Covid 19 Design: A clinical trial with a control and test group, one (...) -based stress coping skills training on psychological distress in patients with Covid 19 in 1400 (...) years of age and under 60 years of age with Covid 19 disease whose hemodynamic condition is stable and
IRCTID: IRCT20210715051896N1
  1. Comparison of the Effectiveness of Online Multimedia Psycho-educational Interventions with routine Psychological Care on the Perceived Stress and Resilience of hospitalized Patients with COVID-19
  2. A Comparative Study on the Efficacy of Meaning-Centered Pain Coping Skills Training and Mindfulness-Based Stress Reduction on Pain Levels, Pain Self-efficacy, Death Anxiety, and Life Expectancy in Breast Cancer Patients
  3. Effect of Stress Management Program on Psychological Distress of Cancer Patients and Caring Burden and Quality of Life of Their Caregivers during the COVID-19 Epidemic
  4. The efficacy of mindfulness based stress reduction program on mental well-being and quality of life in patients with COVID-19 after discharge: A Randomized Control Trial
  5. The effectiveness of online mindfulness training based on stress reduction (MBSR) on mental health and quality of work life of nurses fighting on the frontlines against COVID-19
  6. The study of effects meta-cognitive skills training based -on mindfulness on depression, anxiety, stress and well being of systemic lupus erythematosus patients
  7. Effectiveness of stress coping skills training on resiliency mothers with exceptional children
  8. A comparison of the effect of mindfulness-based stress reduction (MBSR) and psychoeducation on coping skills in caregivers of dementia patients
  9. The Impact of Mindfulness-based Stress Reduction on Sleep Quality in Women Suffering from Multiple Sclerosis in Ahwaz
  10. The effect of group teaching technique of attention training technique and detached- mindfulness on the thought action fusion in students with anxiety and stress syndrome
Study aim: evaluation of the effects of Bromelain, Curcumin and Epigallocatechin in the treatment of outpatient Covid-19 infection. Design: 300 Covid-19 positive patients over 18 year old referred (...) and exclusion criteria: Inclusion criteria: Patients with Covid-19 over 18 years Exclusion criteria
IRCTID: IRCT20210724051971N1
the treatment of the sever phase of the inflammatory phase of Covid-19 pneumonia Design: Clinical (...) in the severe inflammatory phase of Covid-19 pneumonia and are hospitalized in Omid Hospital in Isfahan. Patients in both groups will receive treatments based on the Covid-19 treatment protocol
IRCTID: IRCT20201203049585N2
Loading...